Camp4 Therapeutics (CAMP) Cash Flow: Operating & Free Cash Flow

Camp4 Therapeutics Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Camp4 Therapeutics Corporation (CAMP) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Nov 2023	Feb 2023	Dec 2022	Feb 2022	Feb 2021	Feb 2020	Feb 2019	Feb 2018
Operating Activities
Net Income	-80.40	-51.79	-49.29	-49.29	-44.19	-44.19	-27.99	-56.31	-79.30	18.40	16.62
Depreciation & Amortization	1.64	1.70	1.68	1.68	0.88	0.88	22.80	22.00	23.31	9.79	22.96
Stock Based Compensation	4.00	4.03	2.91	2.91	1.38	1.38	11.32	11.36	10.67	9.54	9.30
Change in Working Capital	13.01	-1.33	-1.27	-0.15	0.37	1.70	1.59	10.96	3.74	-24.74	-9.77
Change in Accounts Receivable	0.00	0.00	-	0.00	0.00	-	1.44	1.62	7.55	-4.02	-6.45
Change in Inventory	0.00	0.00	-	0.00	0.00	-	5.16	8.69	-1.44	5.04	-6.52
Change in Accounts Payable	-1.03	0.17	-1.12	0.00	0.00	1.33	0.00	0.00	0.00	0.00	0.00
Change in Other Working Capital	14.04	1.83	-0.02	-0.15	0.37	-1.52	-5.01	0.65	-2.37	-25.75	3.20
Other Operating Activities	32.21	1.83	1.82	0.71	3.02	1.69	-11.94	40.56	53.13	34.75	27.79
Net Cash from Operating Activities	-29.55	-45.56	-44.16	-44.16	-38.54	-38.54	-4.22	28.59	11.54	47.74	66.89
Investing Activities
Capital Expenditures	-0.28	-0.44	-0.68	-0.68	-4.03	-4.03	-13.30	-11.36	-21.30	-10.40	-8.34
Acquisitions	0.04	0.00	-	0.00	0.00	-	0.00	0.00	-60.65	-13.03	0.00
Purchases of Investments	0.00	0.00	-	0.00	0.00	-	0.00	-6.26	-19.54	-50.36	-38.08
Sales/Maturities of Investments	0.00	0.00	-	0.00	0.00	-	0.00	6.26	37.06	56.36	22.38
Other Investing Activities	0.00	0.00	-	0.00	0.00	-	5.72	-2.34	16.26	1.65	-18.11
Net Cash from Investing Activities	-0.24	-0.44	-0.68	-0.68	-4.03	-4.03	-7.58	-13.69	-65.70	-21.79	-26.45
Financing Activities
Debt Repayment	-0.21	-0.36	-0.27	0.12	-0.09	-0.09	0.00	0.00	0.00	0.00	0.00
Common Stock Issued	61.17	76.35	0.19	0.00	0.00	0.06	0.00	0.00	0.00	0.00	0.00
Common Stock Repurchased	0.00	0.00	-	0.00	0.00	-	0.00	0.00	0.00	-49.00	0.00
Other Financing Activities	14.93	-4.44	-0.32	0.19	100.25	-0.09	-2.64	-27.32	-94.82	98.50	-2.26
Net Cash from Financing Activities	75.89	71.66	0.30	0.30	100.16	100.16	-2.64	-27.32	-94.82	98.50	-2.26
Summary
Effect of Forex Changes on Cash	0.00	0.00	-	0.00	25.60	-	-0.97	-0.36	-0.12	-0.55	0.72
Net Change in Cash	46.09	25.66	-44.53	-44.53	83.19	57.59	-15.40	-12.78	-149.10	123.90	38.90
Cash at Beginning of Period	65.66	40.00	84.54	84.54	26.95	26.95	94.62	107.40	256.50	132.60	93.71
Cash at End of Period	111.76	65.66	40.00	40.00	110.14	84.54	79.22	94.62	107.40	256.50	132.60
Free Cash Flow	-29.83	-46.00	-44.83	-44.83	-42.57	-42.57	-17.52	17.23	-9.76	37.34	58.56

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Camp4 Therapeutics Cash Flow

What is Camp4 Therapeutics's free cash flow?

Camp4 Therapeutics had negative free cash flow of $29.83M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$29.55M minus $279.00K of capital expenditures.

How much does Camp4 Therapeutics spend on capital expenditures?

Camp4 Therapeutics spent $279.00K on capital expenditures in fiscal 2025, compared with $441.00K a year earlier.

Does Camp4 Therapeutics pay dividends or buy back shares?

Camp4 Therapeutics's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition